Anti-ZBTB8OS monoclonal antibody

Pre-made anti-ZBTB8OS monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZBTB8OS/ZBTB8OS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2816-Ab-1/ GM-Tg-hg-IP2816-Ab-2Anti-Human ZBTB8OS monoclonal antibodyHuman
GM-Tg-rg-IP2816-Ab-1/ GM-Tg-rg-IP2816-Ab-2Anti-Rat ZBTB8OS monoclonal antibodyRat
GM-Tg-mg-IP2816-Ab-1/ GM-Tg-mg-IP2816-Ab-2Anti-Mouse ZBTB8OS monoclonal antibodyMouse
GM-Tg-cynog-IP2816-Ab-1/ GM-Tg-cynog-IP2816-Ab-2Anti-Cynomolgus/ Rhesus macaque ZBTB8OS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2816-Ab-1/ GM-Tg-felg-IP2816-Ab-2Anti-Feline ZBTB8OS monoclonal antibodyFeline
GM-Tg-cang-IP2816-Ab-1/ GM-Tg-cang-IP2816-Ab-2Anti-Canine ZBTB8OS monoclonal antibodyCanine
GM-Tg-bovg-IP2816-Ab-1/ GM-Tg-bovg-IP2816-Ab-2Anti-Bovine ZBTB8OS monoclonal antibodyBovine
GM-Tg-equg-IP2816-Ab-1/ GM-Tg-equg-IP2816-Ab-2Anti-Equine ZBTB8OS monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2816-Ab-1/ GM-Tg-hg-IP2816-Ab-2; GM-Tg-rg-IP2816-Ab-1/ GM-Tg-rg-IP2816-Ab-2;
GM-Tg-mg-IP2816-Ab-1/ GM-Tg-mg-IP2816-Ab-2; GM-Tg-cynog-IP2816-Ab-1/ GM-Tg-cynog-IP2816-Ab-2;
GM-Tg-felg-IP2816-Ab-1/ GM-Tg-felg-IP2816-Ab-2; GM-Tg-cang-IP2816-Ab-1/ GM-Tg-cang-IP2816-Ab-2;
GM-Tg-bovg-IP2816-Ab-1/ GM-Tg-bovg-IP2816-Ab-2; GM-Tg-equg-IP2816-Ab-1/ GM-Tg-equg-IP2816-Ab-2
Products NameAnti-ZBTB8OS monoclonal antibody
Formatmab
Target NameZBTB8OS
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZBTB8OS monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2816-Ag-1Recombinant multi-species ARCH/ ZBTB8OS/ ARCH2 protein


    Target information

    Target IDGM-IP2816
    Target NameZBTB8OS
    Gene ID339487,67106,297885,708590,478150,101100986,613795,100070183
    Gene Symbol and Synonyms2010001H09Rik,2310028N13Rik,ARCH,ARCH2,Archm,RGD1562249,ZBTB8OS,Zbtb8os-ps1
    Uniprot AccessionQ8IWT0,Q2YDE7
    Uniprot Entry NameARCH_HUMAN,ARCH_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176261
    Target ClassificationN/A

    The target: ZBTB8OS, gene name: ZBTB8OS, also named as ARCH, ARCH2. Predicted to enable metal ion binding activity. Involved in tRNA splicing, via endonucleolytic cleavage and ligation. Part of tRNA-splicing ligase complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.